RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DENTONE C
Collezione ASL Città di Torino

Items : 14

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. in AIDS patient care and STDs / AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089.

2021
AOU Alessandria
ASL Città di Torino

Dentone C; Bandera A; Cenderello G; Guadagnino G; Angioni G; Vichi F; Maggi P; Cascio A; Martinelli CV; Valsecchi L; Rusconi S; Calza L; Celesia BM; Sarchi E; Pellicanò GF; De Socio GV; Gulminetti R; Molteni C; Menzaghi B; Squillace N; Ricci ED; Orofino G; Taramasso L; De Vito A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;

The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study. in Open forum infectious diseases / Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov.

2021
ASL Città di Torino

Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M;

Factors Associated With Weight Gain in People Treated With Dolutegravir. in Open forum infectious diseases / Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun.

2020
AOU Alessandria
ASL Città di Torino

Dentone C; Vichi F; Maggi P; Bolla C; Cascio A; Valsecchi L; Martinelli CV; Conti F; Calza L; Celesia BM; Pagnucco L; Pellicanò GF; Madeddu G; De Socio GV; Menzaghi B; Squillace N; Orofino G; Ricci E; Bonfanti P; Taramasso L; Angioni G; Mastroianni A; Falasca K; Cenderello G; Di Biagio A;

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort. in Infection and drug resistance / Infect Drug Resist. 2020 Jul 14;13:2291-2300. doi: 10.2147/IDR.S260449. eCollection 2020.

2020
ASL Città di Torino

Bonfanti P; De Vito A; Ricci E; Menzaghi B; Orofino G; Squillace N; Molteni C; De Socio GV; Salomoni E; Celesia BM; Dentone C; Colombo V; Madeddu G;

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project. in Infection and drug resistance / Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019.

2019
ASL Città di Torino

Bagella P; Squillace N; Ricci E; Gulminetti R; De Socio GV; Taramasso L; Pellicanò G; Menzaghi B; Celesia BM; Dentone C; Orofino G; Bonfanti P; Madeddu G;

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? in The Journal of allergy and clinical immunology / J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov

2018
ASL Città di Torino

Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G;

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project. in Infection and drug resistance / Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018.

2018
ASL Città di Torino

Bagella P; De Socio GV; Ricci E; Menzaghi B; Martinelli C; Squillace N; Maggi P; Orofino G; Calza L; Carenzi L; Celesia BM; Penco G; Di Biagio A; Valsecchi L; Vichi F; Colombo V; Parruti G; Dentone C; Falasca K; Bonfanti P; Madeddu G;

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc. in International journal of STD & AIDS / Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

2017
ASL Città di Torino

Dentone C; Sterrantino G; Signori A; Cenderello G; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Giacomini M; Bruzzone B; Francisci D; Di Biagio A;

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells. in Journal of virology / J Virol. 2017 Nov 14;91(23):e00647-17. doi: 10.1128/JVI.00647-17. Print 2017 Dec 1.

2017
ASL Città di Torino

Marras F; Casabianca A; Bozzano F; Ascierto ML; Orlandi C; Di Biagio A; Pontali E; Dentone C; Orofino G; Nicolini L; Taramasso L; Magnani M; Marincola FM; Wang E; Moretta L; De Maria A;

'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation. in Nature communications / Nat Commun. 2015 Oct 5;6:8109. doi: 10.1038/ncomms9109.

2015
ASL Città di Torino

Bozzano F; Marras F; Ascierto ML; Cantoni C; Cenderello G; Dentone C; Di Biagio A; Orofino G; Mantia E; Boni S; De Leo P; Picciotto A; Braido F; Antonini F; Wang E; Marincola F; Moretta L; De Maria A;

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 No

2015
ASL Città di Torino

Madeddu G; De Socio GV; Ricci E; Quirino T; Orofino G; Carenzi L; Franzetti M; Parruti G; Martinelli C; Vichi F; Penco G; Dentone C; Celesia BM; Maggi P; Libertone R; Bagella P; Di Biagio A; Bonfanti P;

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12.

2015
ASL Città di Torino

Taramasso L; Madeddu G; Ricci E; De Socio GV; Menzaghi B; Orofino G; Passerini S; Franzetti M; Maggi P; Dentone C; Martinelli C; Celesia BM; Penco G; Libertone R; Quirino T; Bonfanti P; Di Biagio A;

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. in AIDS (London, England) / AIDS. 2014 Apr 24;28(7):1071-4. doi: 10.1097/QAD.0000000000000194.

2014
ASL Città di Torino

Dentone C; Di Biagio A; Parodi A; Bozzano F; Fraccaro P; Signori A; Cenderello G; Mantia E; Orofino G; De Maria A; Filaci G; Fenoglio D;

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

2014
ASL Città di Torino

Dentone C; Fenoglio D; Signori A; Cenderello G; Parodi A; Bozzano F; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Kalli F; Marras F; Fraccaro P; Giacomini M; Cassola G; Bruzzone B; Ferrea G; Viscoli C; Filaci G; De Maria A; Di Biagio A;